Swedish Pharma Stock News

Apotea (OM:APOTEA) has wrapped up FY 2025 with fourth quarter revenue of SEK 1,856 million, basic EPS of SEK 0.15 and net income of SEK 15.4 million, while on a trailing twelve month basis it recorded revenue of SEK 7.2 billion, basic EPS of SEK 2.20 and net income of SEK 228.7 million. Over recent periods the company has reported quarterly revenue of SEK 1,738.5 million in Q4 2024, SEK 1,753.5 million in Q1 2025, SEK 1,826.2 million in Q2 2025 and SEK 1,769.3 million in Q3 2025. Over the...

Electrolux Professional (OM:EPRO B) is in focus after reporting full year 2025 earnings, with lower sales and net income compared with the previous year, alongside a CEO transition and an announced annual dividend. See our latest analysis for Electrolux Professional. At a share price of SEK61.6, Electrolux Professional has seen a 1 year total shareholder return decline of 16.1%, even though the 3 and 5 year total shareholder returns of 20.43% and 38.45% are still positive. This suggests...

Fasadgruppen Group (OM:FG) FY 2025 earnings snapshot Fasadgruppen Group (OM:FG) has wrapped up FY 2025 with Q4 revenue of SEK1.46b and a basic EPS loss of SEK3.08, capping a trailing twelve month EPS loss of SEK2.16 on SEK5.45b in revenue. Over recent quarters, the company has reported revenue of SEK1.38b in Q3 2025 and SEK1.46b in Q4 2025. Quarterly EPS moved from SEK0.59 in Q3 2025 to a loss of SEK3.08 in Q4 2025, indicating that solid revenue scale is coinciding with pressured...

Bonava FY 2025 Earnings: Volatile Quarters Set the Stage for a Turnaround Story Bonava (OM:BONAV B) closed FY 2025 with a sharp swing in the fourth quarter, posting revenue of SEK3.3b and EPS of SEK0.71, compared with SEK3.1b of revenue and EPS of SEK0.49 in the same quarter a year earlier. Over the past year the company has seen quarterly revenue move between SEK1.1b and SEK3.3b, while EPS has ranged from a loss of SEK0.70 in Q1 2025 to a profit of SEK0.71 in Q4. This took place against a...

Bergman & Beving (OM:BERG B) has reported Q3 2026 revenue of SEK1,268 million, with basic EPS of SEK2.17 and net income of SEK58 million, while revenue growth over the last 12 months has run at 2.8% a year against a Swedish market contraction of 0.3% a year. Over recent quarters the company has seen revenue move between SEK1,144 million and SEK1,319 million and basic EPS has ranged from a loss of SEK7.81 to a profit of SEK2.17, which leaves margins in focus as investors weigh a return toward...

Dynavox Group AB (publ) has reported its full-year 2025 results, with sales rising to SEK 2,467 million and net income reaching SEK 166 million, alongside higher basic and diluted earnings per share from continuing operations compared with the prior year. The combination of solid top-line expansion and improving earnings per share suggests that the company has been converting revenue growth into stronger underlying profitability. Next, we will examine how this improvement in earnings per...

AddLife (OM:ALIF B) has just closed FY 2025 with fourth quarter revenue of SEK2.7b and Basic EPS of SEK2.13, capping a year in which trailing twelve month revenue reached SEK10.4b and EPS came in at SEK4.60. Over recent periods the company has seen quarterly revenue range from SEK2.43b to SEK2.81b and Basic EPS move between SEK0.20 and SEK2.13. Reported earnings growth over the last 12 months was 122.2% and net profit margin moved from 2.4% to 5.4%. For investors, the key question is whether...

Stillfront Group (OM:SF) closed out FY 2025 with Q4 revenue of SEK 1.4b and a basic EPS loss of SEK 4.72, alongside trailing 12 month figures showing revenue of SEK 6.1b and a basic EPS loss of SEK 4.75. Over the past six reported quarters, revenue has moved from SEK 1.8b in Q4 2024 to SEK 1.4b in Q4 2025. Quarterly basic EPS has swung between a profit of SEK 0.11 in Q3 2025 and a loss of SEK 14.38 in Q4 2024, setting up a results season where investors are likely to focus heavily on how...

Peab (OM:PEAB B) has wrapped up FY 2025 with Q4 revenue of SEK17.3b and basic EPS of SEK2.92, alongside net income of SEK829m, giving investors a fresh read on how the year closed out. The company has seen quarterly revenue move between SEK10.8b and SEK17.3b over the past four quarters. Basic EPS has ranged from a loss of SEK1.30 per share in Q1 2025 to SEK3.90 in Q4 2024, setting a wide earnings backdrop for today’s numbers and a trailing twelve month EPS of SEK4.74. With trailing net profit...

In January 2026, Bravida Norway announced it had signed a contract with Backe Vestfold Telemark AS to install electrical, heating and plumbing systems for a 142-room hotel and related infrastructure in the growing Skien Brygge area in southern Norway. The project, which includes a tailored hotel room control system and an energy hub designed to serve both the hotel and future construction phases, underscores Bravida’s role in complex, multi-phase urban development projects. We’ll now examine...

Cloetta (OM:CLA B) has wrapped up FY 2025 with Q4 revenue of SEK 2.2b and basic EPS of SEK 0.82, set against trailing twelve month revenue of SEK 8.5b and EPS of SEK 2.78 that accompany trailing net income of SEK 791m. The company has seen quarterly revenue range from SEK 2.0b to SEK 2.3b through 2025, while basic EPS has moved between SEK 0.41 and SEK 0.89 across the four reported quarters. This gives investors a fuller picture of how earnings have translated into a trailing net profit...

Holmen AB’s year-end 2025 report showed quarterly sales of SEK 5,183 million and net income of SEK 581 million, alongside a proposed increase in the ordinary dividend from SEK 9 to SEK 9.5 per share. Despite weaker sales and operational headwinds, management highlighted solid full-year profitability, a low-leverage balance sheet and a continued focus on shareholder returns through higher ordinary and extra dividends. We will now examine how the dividend increase, alongside mixed operating...

NOBA Bank Group (OM:NOBA) capped FY 2025 with Q4 total revenue of SEK 1,999 million and basic EPS of SEK 1.906, while trailing 12 month revenue stood at SEK 7.5 billion and EPS at SEK 6.826. Over the past few quarters, total revenue has moved from SEK 1,548 million in Q4 2024 to SEK 1,999 million in Q4 2025, with quarterly basic EPS stepping from SEK 1.078 in Q3 2024 to SEK 1.906 in Q4 2025 as investors weigh those stronger headline numbers against a 45.5% net margin and the credit risks...

In late January 2026, Synsam AB repurchased 125,000 shares under its ongoing SEK 160 million buy-back programme aimed at reducing share capital and adjusting its capital structure, bringing its treasury shareholding to about 5.47 million out of roughly 148 million shares outstanding. This continued use of buy-backs highlights Synsam’s active capital management and may influence how investors assess the company’s capital allocation priorities. We’ll now examine how Synsam’s ongoing share...

Vitrolife FY 2025 earnings snapshot Vitrolife (OM:VITR) closed FY 2025 with fourth quarter revenue of SEK 892 million and a loss per share of SEK 39.23, as net income excluding extra items came in at a loss of SEK 5,313 million. Over the past year, the company has seen quarterly revenue range from SEK 835 million to SEK 892 million, while EPS moved from SEK 1.03 in Q4 2024 to SEK 0.74 in Q2 and Q1 2025, before swinging to a loss in Q4. For investors, the headline story is that solid top line...

If you are wondering whether Sandvik's share price reflects its underlying value, you are not alone. That question is exactly what this article will focus on. The stock most recently closed at SEK 370.8, with returns of 7.0% over the past week, 21.6% over the past month, 22.9% year to date, 70.7% over the past year, 80.4% over three years and 106.1% over five years. Recent news around Sandvik has included ongoing interest in its position as a key industrial player, along with coverage that...

Securitas (OM:SECU B) has just combined a refreshed dividend proposal with its latest earnings report, putting both income and profitability in focus for shareholders watching how the business is performing through 2025. See our latest analysis for Securitas. The 1 day share price return of 7.47% and 90 day share price return of 13.76% suggest positive momentum around the SEK159.6 share price. The 3 year total shareholder return of 85.16% points to strong longer term gains. If this mix of...

What Swedish Orphan Biovitrum’s latest earnings mean for investors Swedish Orphan Biovitrum (OM:SOBI) has drawn fresh attention after reporting full year 2025 results, with sales of SEK 28,238 million, net income of SEK 478 million, and sharply lower earnings per share versus 2024. See our latest analysis for Swedish Orphan Biovitrum. Against this earnings backdrop, the share price has been firming, with a 7.37% 30 day share price return and a 9.47% 1 year total shareholder return. The 5 year...

Husqvarna (OM:HUSQ B) is back in focus after reporting Q4 and full year 2025 results, outlining a new 2030 plan, announcing leadership changes, and proposing a higher dividend for shareholders. See our latest analysis for Husqvarna. The Q4 report, 2030 plan, leadership reshuffle and dividend proposal arrived after a period of weaker share price momentum, with a 1 day share price return of 8.38% decline and a 1 year total shareholder return of 19.42% decline pointing to pressure that has built...

Svenska Handelsbanken AB (publ) has reported full-year 2025 results, with net income of SEK 23,727 million and basic earnings per share of SEK 12.12, down from the prior year. The bank also proposed raising its total dividend to SEK 17.50 per share, including an ordinary dividend of SEK 8.00, signaling confidence in its ability to return capital to shareholders despite lower earnings. Against this backdrop, we will examine how the higher proposed dividend shapes Handelsbanken’s investment...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

BioGaia recently reported preliminary fourth-quarter figures indicating that both sales and operating profit exceeded market expectations, with margins also coming in higher than anticipated. This early confirmation of strong profitability further underlines BioGaia’s positioning in the global probiotics market ahead of its detailed Q4 2025 report on 12 February 2026. Next, we’ll examine how this stronger-than-expected profitability update may influence BioGaia’s investment narrative and...

Wihlborgs Fastigheter AB (publ) has renewed a six-year lease for 12,000 sqm at the Bricks property in Ideon and signed a separate six-year, 1,000 sqm lease with a government agency, resulting in the building becoming fully leased from May 2026 onward. This shift from historically high vacancy to full occupancy at Bricks underlines how improved services, diversified premises, and sustainability-focused upgrades have turned the Mobilvägen cluster into an attractive hub for around 50 tenants...

As the European market navigates a modest recovery, with the STOXX Europe 600 Index seeing gains amid earnings optimism, investors are keenly observing opportunities that might arise from smaller or newer companies. Penny stocks, though an older term, continue to capture interest by offering potential growth at lower price points. When these stocks are supported by strong financial health and fundamentals, they can present compelling opportunities for those looking to explore underappreciated...